PFIZER
₹4,080.6
37.1 (0.92%)
As on 10 December, 2023 | 21:51 BSE: 500680 NSE: PFIZERISIN: INE182A01018

Pfizer Performance

Day Range

  • Low 4,050.00
  • High 4,091.05
₹ 4,080.6

52 Week Range

  • Low 3,408.00
  • High 4,560.00
₹ 4,080.6
  • Open Price4,050.00
  • Previous Close4,043.50
  • Volume16224

Start SIP in Pfizer

Start SIP

Pfizer Share Price

  • Over 1 Month 3.43%
  • Over 3 Month 6.06%
  • Over 6 Month 2.85%
  • Over 1 Year -9.8%

Pfizer Key Statistics

P/E Ratio 35.7
PEG Ratio -2.4
Market Cap Cr 18,668
Price to Book Ratio 5.8
EPS 131.4
Dividend 1
Relative Strength Index 59.85
Money Flow Index 50.23
MACD Signal 34.3
Average True Range 71.42

Pfizer Investment Rating

  • Master Rating:
  • Pfizer (Nse) has an operating revenue of Rs. 2,300.96 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 34% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 2% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Pfizer Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 575531573622637593550
Operating Expenses Qtr Cr 393421391418406401384
Operating Profit Qtr Cr 183111182203232192165
Depreciation Qtr Cr 15162626262734
Interest Qtr Cr 3334344
Tax Qtr Cr 523235501041119
Net Profit Qtr Cr 1499413015131133126
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,5262,674
Operating Expenses Annual Cr 1,6161,775
Operating Profit Annual in Cr 809836
Depreciation Cr 106115
Interest Annual Cr 1310
Tax Annual Cr 200160
Net Profit Annual Cr 624613
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 356667
Cash from Investing Activity Annual Cr -36-575
Cash from Financing Annual Activity Cr -346-181
Net Cash Flow Annual Cr -26-88
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 3,2072,864
Fixed Assets Annual Cr 757870
Total Non Current Assets Annual Cr 1,4761,504
Total Current Assets Annual Cr 2,5252,396
Total Assets Annual Cr 4,0013,901
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 701626
ROE Annual % 1921
ROCE Annual % 2426
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3834
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Pfizer Technicals

EMA & SMA

Current Price
₹4,080.6
37.1 (0.92%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹4,027.73
  • 50 Day
  • ₹3,977.55
  • 100 Day
  • ₹3,939.74
  • 200 Day
  • ₹3,953.82
  • 20 Day
  • ₹4,021.47
  • 50 Day
  • ₹3,967.35
  • 100 Day
  • ₹3,928.52
  • 200 Day
  • ₹3,844.63

Pfizer Resistance and Support

PIVOT
₹4,073.89
Resistance
First Resistance 4,097.77
Second Resistance 4,114.93
Third Resistance 4,138.82
RSI 59.85
MFI 50.23
MACD Single Line 34.30
MACD 33.08
Support
First Resistance 4,056.72
Second Resistance 4,032.83
Third Resistance 4,015.67

Pfizer Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 17,838 1,010,344 56.64
Week 34,905 2,693,952 77.18
1 Month 21,167 1,255,641 59.32
6 Month 26,315 1,813,609 68.92

Pfizer Result Highlights

Pfizer Synopsis

NSE-Medical-Diversified

Pfizer Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2424.76 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2023. Pfizer Ltd. is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311.
Market Cap 18,668
Sales 2,301
Shares in Float 1.65
No of funds 119
Yield 0.86
Book Value 5.82
U/D Vol ratio 2.4
LTDebt / Equity
Alpha -0.05
Beta 0.32

Pfizer

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 63.92%63.92%63.92%63.92%
Mutual Funds 7.39%6.17%5.96%5.97%
Insurance Companies 7.57%8.68%8.89%8.91%
Foreign Portfolio Investors 2.82%2.81%2.8%2.77%
Financial Institutions/ Banks 0.01%0.01%0.01%0.02%
Individual Investors 13.61%13.68%13.7%13.72%
Others 4.68%4.73%4.72%4.69%

Pfizer Management

Name Designation
Ms. Meenakshi Nevatia Managing Director
Mr. Milind Patil Executive Director (Finance) & CFO
Mr. Samir Kazi Executive Director
Mr. Sunil Lalbhai Independent Director
Mr. Pradip Shah Chairman & Ind.Director
Mr. Uday Khanna Independent Director
Ms. Meena Ganesh Independent Director

Pfizer Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Pfizer Corporate Action

Date Purpose Remarks
2023-10-28 Quarterly Results
2023-08-11 Quarterly Results
2023-05-15 Audited Results & Final Dividend
2023-02-09 Quarterly Results
2022-11-11 Quarterly Results
Date Purpose Remarks
2023-08-11 FINAL Rs.35.00 per share(350%)Final Dividend
2023-08-11 SPECIAL Rs.5.00 per share(50%)Special Dividend
2022-09-20 SPECIAL Rs.30.00 per share (300%) Special Interim Dividend
2022-08-19 FINAL Rs.35.00 per share(350%)Dividend

Pfizer MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 41,019
Nippon India Multi Cap Fund - Growth 22,695
Aditya Birla Sun Life ELSS Tax Saver Pyt of Inc Dis cum Cap Wdrl 13,536
SBI Magnum Midcap Fund Regular Growth 13,202
DSP ELSS Tax Saver Fund Regular Plan Growth 11,693

Pfizer FAQs

What is Share Price of Pfizer ?

Pfizer share price is ₹4,080 As on 10 December, 2023 | 21:37

What is the Market Cap of Pfizer ?

The Market Cap of Pfizer is ₹18667.8 Cr As on 10 December, 2023 | 21:37

What is the P/E ratio of Pfizer ?

The P/E ratio of Pfizer is 35.7 As on 10 December, 2023 | 21:37

What is the PB ratio of Pfizer ?

The PB ratio of Pfizer is 5.8 As on 10 December, 2023 | 21:37

Q2FY23